Literature DB >> 25073770

Incidence and factors predicting whooping cough due to parapertussis diagnosis among patients referred to general practitioners, Poland, 2009-2011.

R Tomialoic1,2, P Stefanoff3, I Paradowska-Stankiewicz3, A Zasada4, M Sadkowska-Todys3.   

Abstract

Parapertussis leads to similar symptoms as pertussis, both being caused by bacteria from the genus Bordetella. Poland does not routinely diagnose nor conduct surveillance for parapertussis. We estimated parapertussis incidence and determined predictors of parapertussis diagnosis in the Polish population. Between July 2009 and April 2011, we conducted a prospective cohort study among patients attending 78 general practices. We included patients aged ≥ 3 years, with cough lasting >2 weeks, interviewed patients and collected a nasopharyngeal swab. We confirmed cases by real-time PCR. We estimated parapertussis incidence rates by dividing the number of cases by the summed person-time of observation in respective practices. We assessed predictors of PCR-confirmed parapertussis by comparing cases with patients testing negative. Using logistic regression, we calculated odds ratios (ORs) and 95% confidence intervals (95%CI). We identified 78 cases among 1,231 patients meeting inclusion criteria. The incidence rate was 39/100,000 person-years (95%CI 31-49). The highest rates (140/100,000; 95%CI 74-239), were among children 3-5 years of age and the lowest (24/100,000; 95%CI 13-40) among persons aged 20-39 years of age. Boys aged 3-5 years (7.1; 2.1-25.3) and women aged >40 years (4.1; 1.4-11.7) or living in crowded households (4.3; 1.4-12.9) or contacting persons with prolonged cough (2.3; 1.1-4.5) were more likely to be diagnosed. Our results suggest that laboratory diagnosis could be prioritized for children in the preschool age and women aged over 40 who were referred to their GP with prolonged cough. In the absence of vaccine, post-exposure prophylaxis for close contacts of parapertussis cases could an adequate preventative measure.

Entities:  

Mesh:

Year:  2014        PMID: 25073770     DOI: 10.1007/s10096-014-2214-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Pertussis vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1999-05-07

2.  Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009.

Authors:  Natalia Kurova; Elisabeth Njamkepo; Delphine Brun; Galina Tseneva; Nicole Guiso
Journal:  Res Microbiol       Date:  2010-09-24       Impact factor: 3.992

3.  Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis.

Authors:  Kirsi Nuolivirta; Petri Koponen; Qiushui He; Anne Halkosalo; Matti Korppi; Timo Vesikari; Merja Helminen
Journal:  Pediatr Infect Dis J       Date:  2010-11       Impact factor: 2.129

4.  Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis.

Authors:  A van der Zee; C Agterberg; M Peeters; J Schellekens; F R Mooi
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

5.  Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010.

Authors:  James D Cherry; Brent L Seaton
Journal:  Clin Infect Dis       Date:  2011-12-07       Impact factor: 9.079

6.  Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.

Authors:  E Bergfors; B Trollfors; J Taranger; T Lagergård; V Sundh; G Zackrisson
Journal:  Int J Infect Dis       Date:  1999       Impact factor: 3.623

Review 7.  Re-emergence of pertussis: what are the solutions?

Authors:  Romina Libster; Kathryn M Edwards
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

Review 8.  [Review of the present status of prevention, prophylaxis and therapy of pertussis and parapertussis].

Authors:  A Baće; V Duancić
Journal:  Lijec Vjesn       Date:  1990 Jul-Aug

9.  Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates.

Authors:  P Mastrantonio; P Stefanelli; M Giuliano; Y Herrera Rojas; M Ciofi degli Atti; A Anemona; A E Tozzi
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

10.  Incidence of pertussis in patients of general practitioners in Poland.

Authors:  P Stefanoff; I A Paradowska-Stankiewicz; M Lipke; E Karasek; W Rastawicki; A Zasada; S Samuels; H Czajka; R G Pebody
Journal:  Epidemiol Infect       Date:  2013-07-22       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.